Since the spread of the deadly Ebola Virus, the whole world have been in confusion. Personally, I’m scared, not only because the virus kills faster than AIDS, but because no treatment has yet been found.
Here are the five things to know about “one of the world’s most virulent diseases.” According to World Health Organization…
What is Ebola, and what are its symptoms?
The Ebola virus causes viral hemorrhagic fever, which according to the U.S. Centers for Disease Control and Prevention (CDC), refers to a group of viruses that affect multiple organ systems in the body and are often accompanied by bleeding.
The virus is named after the Ebola River in the Democratic Republic of Congo (formerly Zaire), where one of the first outbreaks occurred in 1976. The same year there was another outbreak in Sudan.
The WHO says there are five different strains of the virus — named after the areas they originated in. Three of these have been associated with large outbreaks of hemorrhagic fever in Africa.
These are the Bundibugyo — an area of Uganda where the virus was discovered in 2007 — Sudan and Zaire sub-types.
There has been a solitary case of Ivory Coast Ebola. This subtype was discovered when a researcher studying wild chimpanzees became ill in 1994 after an autopsy on one of the animals. The researcher recovered.
Finally, Reston Ebola is named after Reston in the U.S. state of Virginia, where this fifth strain of the Ebola virus was identified in monkeys imported from the Philippines. The CDC says while humans have been infected with Ebola Reston, there have been no cases of human illness or death from this sub-type.
What are Ebola’s symptoms?
Early symptoms include sudden onset of fever, weakness, muscle pain, headaches and a sore throat. These symptoms can appear two to 21 days after infection.
The WHO says these nonspecific early symptoms can be mistaken for signs of diseases such as malaria, typhoid fever, meningitis or even the plague.
MSF says some patients may also develop a rash, red eyes, hiccups, chest pains and difficulty breathing and swallowing.
The early symptoms progress to vomiting, diarrhea, impaired kidney and liver function and sometimes internal and external bleeding.
Ebola can only be definitively confirmed by five different laboratory tests.
How is it treated?
There are no specific treatments for Ebola. MSF says patients are isolated and then supported by health care workers.
“This consists of hydrating the patient, maintaining their oxygen status and blood pressure and treating them for any complicating infections,” it says.
There have been cases of healthcare workers contracting the virus from patients, and the WHO has issued guidance for dealing with confirmed or suspected cases of the virus.
Carers are advised to wear impermeable gowns and gloves and to wear facial protection such as goggles or a medical mask to prevent splashes to the nose, mouth and eyes.
MSF says it contained a 2012 outbreak in Uganda by placing a control area around its treatment center. An outbreak is considered over once 42 days — double the incubation period of the disease — have passed without any new cases.
What drugs exist to combat the virus?
Two American missionary workers infected with Ebola were given an experimental drug called ZMapp which seems to have saved their lives. The drug, developed by a San Diego firm, had never been tried before on humans, but it showed promise in small experiments on monkeys.
But rolling out an untested drug during a massive outbreak would also be very difficult, according to MSF. Experimental drugs are typically not mass-produced, and tracking the success of such a drug if used would require extra medical staff where resources are already scarce. ZMapp’s maker says it has very few doses ready for patient use.
There are other experimental drugs out there.Tekmira, a Vancouver-based company that has a $140 million contract with the U.S. Department of Defense to develop an Ebola drug, began Phase 1 trials with its drug in January. But the FDA recently halted the trial, asking for more information.
At least one potential Ebola vaccine has been tested in healthy human volunteers, according to Thomas Geisbert, a leading researcher at the University of Texas Medical Branch. And last week, the NIH announced that a safety trial of another Ebola vaccine will start as early as September.
And in March, the U.S. National Institute of Health awarded a five-year, $28 million grant to establish a collaboration between researchers from 15 institutions who were working to fight Ebola.
“A whole menu of antibodies have been identified as potentially therapeutic, and researchers are eager to figure out which combinations are most effective and why,” a news release about the grant said.
How does Ebola virus spread?
The WHO says it is believed that fruit bats may be the natural host of the Ebola virus in Africa, passing on the virus to other animals.
Humans contract Ebola through contact with the bodily fluids of infected animals or the bodily fluids of infected humans.
MSF says that while the virus is believed to be able to survive for some days in liquid outside an infected organism, chlorine disinfection, heat, direct sunlight, soaps and detergents can kill it.
MSF epidemiologist Kamiliny Kalahne said outbreaks usually spread in areas where hospitals have poor infection control and limited access to resources such as running water.
“People who become sick with it almost always know how they got sick: because they looked after someone in their family who was very sick — who had diarrhea, vomiting and bleeding — or because they were health staff who had a lot of contact with a sick patient,” she said.
-CNN
